Strict glycemic control in diabetic pregnancy - Implications for second-trimester screening for Down syndrome

Prenatal Diagnosis

Volumn 23, Issue 11, 2003, Pages 888-890

  Peled, Y ^a   Gilboa, Y ^a   Perri, T ^a   Shohat, M ^a   Chen, R ^a   Bar, J ^a   Hod, M ^a   Pardo, J ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Alpha fetoprotein; Diabetes; Human chorionic gonadotrophin; Pregnancy; Unconjugated estriol

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN; ESTRIOL;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DELIVERY; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; NEWBORN SCREENING; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; REFERENCE VALUES;

EID: 0344875015     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.719     Document Type: Article

References (13)

1. Baumgarten A, Robinson J. 1988. Prospective study of an inverse relationship between maternal glycosylated hemoglobin and serum alpha-fetoprotein concentrations in pregnant women with diabetes. Am J Obstet Gynecol 159: 77-81.
2. College of American Pathologists. 1992. Report of the FBR/CAP Maternal AFP Screening Survey. College of American Pathologists: Northfield, IL.
3. Evans MI, Harrison HH, O'Brien JE, et al. 2002. Correction for insulin-dependent diabetes in maternal serum alpha-fetoprotein testing has outlived its usefulness. Am J Obstet Gynecol 187: 1084-1086.
4. Fuhrmann K, Reiher H, Sern K, Fischer F, Fischer M, Glockner E. 1983. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 6: 219-223.
5. Green MF, Haddow JE, Palomaki GE, Knight GJ. 1988. Maternal serum alpha-fetoprotein levels in diabetic pregnancies. Lancet 2: 345-346.
6. Hod M, Bar J, Peled Y, et al. 1998. Antepartum management protocol. Timing and mode of delivery in gestational diabetes. Diabetes Care 21(Suppl. 2): B113-B117.
7. Kulch P, Keener S, Matsumoto M, Crandall BF. 1993. Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels. Prenat Diagn 13: 191-195.
8. Pedersen JF, Molsted-Pedersen L. 1981. Early fetal growth delay detected by ultrasound marks increased risk of congenital malformation in diabetic pregnancy. Br Med J 283: 269-271.
9. Sancken U, Bartels I. 2001. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)? Prenat Diagn 21: 383-386.
10. Wald NJ, Cuckle HS, Brock JH, Peto R, Polani PE, Woodford FP. 1977. Maternal serum alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of UK collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1: 1323-1332.
11. Wald NJ, Cuckle HS, Boreham J, Terzian E, Redman C. 1981. The effect of maternal weight on maternal alpha-fetoprotein levels. Br J Obstet Gynecol 88: 1094-1096.
12. Wald NJ, Cuckle HS, Densem JW, Stone RB. 1992. Maternal serum unconjugated oestriol and human chorionic gonadotropin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome. Br J Obstet Gynaecol 99: 51-53.
13. Wenstrom KD, Own J, Boots L, Ethier M. 1995. The influence of maternal weight on human chorionic gonadotropin in the multiple-marker screening test for fetal Down syndrome. Am J Obstet Gynecol 173: 1297-1300.